Uncategorized

QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency

QuTEM AB, a leading provider of transmission electron microscopy services, proudly announces the receipt of GMP Certificates and Manufacturing Permits for Independent Quality Control Laboratories issued by the Swedish Medical Products Agency.

QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency Read More »

Philips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions

Royal Philips a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the Heart Rhythm Annual Meeting in Boston.

Philips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions Read More »

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients

Drug Farm announced the U.S. Food and Drug Administration has cleared the Investigational New Drug application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 inhibitor for clinical evaluation in ROSAH syndrome patients.

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients Read More »

Erasca Announces Pricing of Underwritten Offering of Common Stock – May 17, 2024

Erasca, Inc., a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, announced the pricing of an underwritten offering of 86,486,486 shares of its common stock at a price of $1.85 per share.

Erasca Announces Pricing of Underwritten Offering of Common Stock – May 17, 2024 Read More »

Scroll to Top